Another drug liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist primarily used for diabetes, helps improve insulin sensitivity by promoting weight loss and shows some promise in treating NAFLD. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.